Clin2
NCT05106491Likely a fitNot yet recruiting

Heart pump support for cardiogenic shock

Cardiogenic ShockExtracorporeal Membrane OxygenationECLSVA ECMO

Part of Heart & circulation clinical trials.

This trial tests a device that helps support your heart when it's in cardiogenic shock (a life-threatening condition where the heart can't pump enough blood). The device works alongside standard treatments to improve blood flow and reduce strain on the heart.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
21 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You must be 18 to 85 years old
  • Your heart is not pumping strongly enough, causing very low blood pressure
  • You need medications to keep your blood pressure up
  • You have signs of poor blood flow, like cold skin or low urine output
  • You must have a high lactate level in your blood

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06336655Recruiting· Phase 2
Studying heart pump therapy for severe heart shock

This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.

Salt Lake City, Utah
NCT04184635Recruiting
ECMO for heart-attack shock in the ICU

This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.

Paris
NCT06886113Not yet recruiting
Heart pump support for cardiogenic shock after heart attack

This trial tests a new heart pump device (CorVad) to support the heart in people who are in cardiogenic shock after a heart attack. It may help stabilize blood pressure and improve blood flow, potentially giving the heart time to recover.

Hangzhou, Zhejiang
NCT07769528Recruiting
Heart pump support for severe heart failure

This study tests a device that helps the heart pump blood when it is too weak to do so, even with medicine, after surgery, or while waiting for a transplant. It aims to see if it's safe and works well.

Beijing, Beijing Municipality
NCT05748860Not yet recruiting
Tailored ECMO treatment for cardiogenic shock

This trial studies people who are starting ECMO, a machine that takes over the work of the heart and lungs, to see if a more tailored approach can improve outcomes. If you join, your care may be adjusted based on your specific needs.

NCT06936839Not yet recruiting
Finding the best ECMO flow for cardiogenic shock

This study tests whether adjusting the blood flow rate of an ECMO machine (which helps your heart pump) can improve blood flow to your organs and reduce stress on your heart during the critical early phase of cardiogenic shock. It aims to find the best ECMO settings to help you recover.

Montpellier, Occitanie

Hear when a new Cardiogenic Shock trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.